Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety of Arformoterol in COPD
NCT00064415Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Jun 2002
- Primary completion
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of arformoterol in chronic obstructive pulmonary disease (COPD), sponsored by Sumitomo Pharma America. Started Jun 2002; status: completed.
02
Drugs
arformoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00064415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00064415.